Literature DB >> 18926100

Myelodysplastic syndromes.

Peter L Greenberg1, Eyal Attar, Minoo Battiwalla, John M Bennett, Clara D Bloomfield, Carlos M DeCastro, H Joachim Deeg, Harry P Erba, James M Foran, Guillermo Garcia-Manero, Steven D Gore, David Head, Lori J Maness, Michael Millenson, Stephen D Nimer, Margaret R O'Donnell, Hussain I Saba, Paul J Shami, Kathy Spiers, Richard M Stone, Martin S Tallman, Peter Westervelt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18926100

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  8 in total

1.  Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology.

Authors:  Pablo Gargallo; Merche Molero; Cristina Bilbao; Ruth Stuckey; Estrella Carrillo-Cruz; Lourdes Hermosín; Olga Pérez-López; Antonio Jiménez-Velasco; Elena Soria; Marián Lázaro; Paula Carbonell; Yania Yáñez; Iria Gómez; Marta Izquierdo-García; Jennifer Valero-García; Carlos Ruiz; Esperanza Such; Inés Calabria
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

Review 2.  Border between aplastic anemia and myelodysplastic syndrome.

Authors:  Hirohito Yamazaki; Shinji Nakao
Journal:  Int J Hematol       Date:  2013-04-24       Impact factor: 2.490

3.  An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes.

Authors:  Jacqueline S Garcia; Nitin Jain; Lucy A Godley
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

4.  Increased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure.

Authors:  Yu Seiki; Yumi Sasaki; Kohei Hosokawa; Chizuru Saito; Naomi Sugimori; Hirohito Yamazaki; Akiyoshi Takami; Shinji Nakao
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

Review 5.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

6.  Systemic vasculitis with prolonged pyrexia, recurrent facial urticaria, skin nodules, pleural effusions and venous thrombosis: an unusual presentation of an uncommon disease.

Authors:  Imad Salah Hassan; Javeed Dar
Journal:  Ger Med Sci       Date:  2011-10-19

7.  Synergistic inhibitory effects of deferasirox in combination with decitabine on leukemia cell lines SKM-1, THP-1, and K-562.

Authors:  Nianyi Li; Qinfen Chen; Jingwen Gu; Shuang Li; Guangjie Zhao; Wei Wang; Zhicheng Wang; Xiaoqin Wang
Journal:  Oncotarget       Date:  2017-05-30

Review 8.  Phosphoinositide-Dependent Signaling in Cancer: A Focus on Phospholipase C Isozymes.

Authors:  Eric Owusu Obeng; Isabella Rusciano; Maria Vittoria Marvi; Antonietta Fazio; Stefano Ratti; Matilde Yung Follo; Jie Xian; Lucia Manzoli; Anna Maria Billi; Sara Mongiorgi; Giulia Ramazzotti; Lucio Cocco
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.